CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival.

BRCA2 CDK5RAP3 DNA repair breast cancer chemoresistance

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
12 Jan 2022
Historique:
received: 27 09 2021
revised: 27 10 2021
accepted: 30 10 2021
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

BRCA2 is essential for homologous recombination DNA repair.

Identifiants

pubmed: 35053516
pii: cancers14020353
doi: 10.3390/cancers14020353
pmc: PMC8773632
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States

Références

Clin Cancer Res. 2012 Dec 1;18(23):6400-6
pubmed: 23071261
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):686-91
pubmed: 21148102
J Biol Chem. 2005 May 27;280(21):20651-9
pubmed: 15790566
J Med Genet. 2016 May;53(5):298-309
pubmed: 26921362
Environ Mol Mutagen. 2006 Jan;47(1):56-66
pubmed: 16180205
Nat Rev Cancer. 2002 Apr;2(4):251-65
pubmed: 12001987
Breast Cancer Res. 2011 Apr 05;13(2):R40
pubmed: 21466675
Orphanet J Rare Dis. 2020 Jun 30;15(1):170
pubmed: 32605631
Cancer Lett. 2020 Mar 1;472:1-7
pubmed: 31830560
Mol Cell Biol. 2004 Nov;24(21):9305-16
pubmed: 15485900
PLoS Genet. 2008 Jun 27;4(6):e1000110
pubmed: 18584027
Oncogene. 2002 Aug 1;21(33):5188-92
pubmed: 12140769
Biochem J. 2006 Jan 15;393(Pt 2):489-501
pubmed: 16173922
Cancer Res. 2011 Sep 1;71(17):5792-805
pubmed: 21799032
Radiat Res. 2014 Feb;181(2):193-207
pubmed: 24527691
Cancer Res. 2013 Jan 1;73(1):265-75
pubmed: 23108138
Nat Genet. 2001 Dec;29(4):418-25
pubmed: 11694875
JAMA Oncol. 2015 Oct;1(7):943-51
pubmed: 26270727
Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):a016600
pubmed: 25833843
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18490-5
pubmed: 19001271
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
PLoS One. 2013 Dec 18;8(12):e82241
pubmed: 24367507
Clin Cancer Res. 2016 Apr 1;22(7):1653-62
pubmed: 26813360
Nature. 2015 Nov 26;527(7579):525-530
pubmed: 26560028
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Genes Dev. 1999 Oct 15;13(20):2633-8
pubmed: 10541549
Nucleic Acids Res. 2016 May 19;44(9):4189-99
pubmed: 26873923
Hum Mol Genet. 2015 Sep 15;24(18):5345-55
pubmed: 26130695
Hum Mutat. 2014 Feb;35(2):151-64
pubmed: 24323938
PLoS One. 2011;6(10):e26608
pubmed: 22028922
Pharmacol Ther. 2016 Apr;160:65-83
pubmed: 26896565
Oncogene. 2013 Jul 25;32(30):3552-8
pubmed: 22964643
Cancer Cell. 2007 Sep;12(3):239-51
pubmed: 17785205
Cancer Treat Rev. 2015 Jan;41(1):35-45
pubmed: 25467108
Exp Cell Res. 2014 Nov 15;329(1):78-84
pubmed: 25447315
Curr Opin Genet Dev. 2015 Aug;33:32-40
pubmed: 26254775
Nat Commun. 2018 Mar 6;9(1):967
pubmed: 29511213
EMBO J. 2001 Sep 3;20(17):4704-16
pubmed: 11532935
Nat Genet. 2010 May;42(5):410-4
pubmed: 20400964
Breast Cancer Res. 2007;9(2):104
pubmed: 17466083
PLoS One. 2016 Jan 19;11(1):e0147230
pubmed: 26784987
Cell Res. 2009 Apr;19(4):458-68
pubmed: 19223857
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8632-7
pubmed: 23657012
J Clin Invest. 2017 Aug 1;127(8):3013-3027
pubmed: 28691929
Cancer Cell. 2007 Feb;11(2):103-5
pubmed: 17292821
Nature. 2015 Nov 26;527(7579):472-6
pubmed: 26560033
Nat Genet. 2007 Feb;39(2):165-7
pubmed: 17200668
PLoS Biol. 2011 Nov;9(11):e1001199
pubmed: 22110403
Breast Cancer Res. 2010;12(6):R109
pubmed: 21182766
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
Clin Cancer Res. 2020 Jun 15;26(12):3044-3057
pubmed: 32005748
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Chem Biol. 2015 Nov 19;22(11):1491-1504
pubmed: 26548611
Cancer Res. 2009 Apr 15;69(8):3625-33
pubmed: 19336573

Auteurs

Jordi Minguillón (J)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

María José Ramírez (MJ)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Llorenç Rovirosa (L)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Pilar Bustamante-Madrid (P)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Cristina Camps-Fajol (C)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Gorka Ruiz de Garibay (G)

Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

Hermela Shimelis (H)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, USA.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901, USA.

Helena Montanuy (H)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Roser Pujol (R)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Gonzalo Hernandez (G)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Massimo Bogliolo (M)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Pau Castillo (P)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Penny Soucy (P)

Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC G1E 6W2, Canada.

Griselda Martrat (G)

Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

Antonio Gómez (A)

Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

Daniel Cuadras (D)

Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

María J García (MJ)

Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.

Javier Gayarre (J)

Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.

Conxi Lázaro (C)

Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

Javier Benítez (J)

Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.

Fergus J Couch (FJ)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55901, USA.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901, USA.

Miquel Angel Pujana (MA)

Program against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.

Jordi Surrallés (J)

Genomic Instability Syndromes and DNA Repair Group and Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER) U-745, 08041 Barcelona, Spain.

Classifications MeSH